Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Bitbrain

Bitbrain_logo
22
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Bitbrain is a neurotech company that combines neuroscience, artificial intelligence and hardware to develop neurotechnology applications that enhance people's lives. We are currently focused on a neurostimulation device to delay dementia onset.

Zaragoza, Aragon, Spain

Send a message

  • 23

    employees

  • €900,000

    turnover

Anglais

Bitbrain

Anglais

Bitbrain is a Spanish company founded in 2010 to lead the penetration of neurotechnology into our daily lives.

The company has invested more than 4.5 million euros for the research and initial validation of Elevvo, a new treatment to delay the onset of dementia. This is a high-risk line of research, but with very high growth potential. 

Dementia is a worldwide public health priority with no treatment available. The fact that all treatments for dementia have...

See more

Bitbrain is a Spanish company founded in 2010 to lead the penetration of neurotechnology into our daily lives.

The company has invested more than 4.5 million euros for the research and initial validation of Elevvo, a new treatment to delay the onset of dementia. This is a high-risk line of research, but with very high growth potential. 

Dementia is a worldwide public health priority with no treatment available. The fact that all treatments for dementia have failed in clinical trials indicate that the brain pathology begins years before the onset of the disease and can be irreversible by the time of diagnosis. For this reason, Bitbrain is focused on delaying dementia in patients in the preclinical stages of the disease.

So far, Elevvo has demonstrated its ability to significantly increase cognitive function in seniors with cognitive deterioration, producing a cognitive enhancement of 25% in 8 hours of treatment, and obtaining 2.5 times more effects in 4.2 times less time than any other alternative. 

Bitbrain intends to bring Elevvo to the EU and global marketplaces, improving lives and delivering substantial value for the EU economy. However, successful market uptake requires further development and clinical validation.

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
329 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1627 Members